Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
XENE compared with DFTX: revenue, margins and what each company keeps, and the suppliers and customers both name
XENE
Xenon Pharmaceuticals Inc.
Change
Mkt cap
Revenue
Revenue
DFTX
Definium Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
XENE
Xenon Pharmaceuticals Inc.
vs
DFTX
Definium Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only XENE
2
NBIX
Neurocrine Biosciences
supplier
BHC
Bausch Health
supplier
Shared
0
No disclosed counterparties: DFTX.
Only DFTX
0
None
Role chip = supplier or customer
Source: SEC EDGAR
XENE
Xenon Pharmaceuticals Inc.
Change
39.03
▲
+2.09%
Mkt cap
$3.7B
Revenue
$8M
Q1 FY25
DFTX
Definium Therapeutics, Inc.
Change
32.26
▼
−3.45%
Regular session
Nov 4 '26
Mkt cap
$4.4B
Revenue
—
vs
Compare
Regular session
Nov 4 '26
XENE
Xenon Pharmaceuticals Inc.
vs
DFTX
Definium Therapeutics, Inc.
39.03
▲
+2.09%
Price
32.26
▼
−3.45%
$3.7B
Mkt cap
$4.4B
Q1 FY25
$8M
Revenue
—
Change
Change
XENE
39.03
▲
+2.09%
vs
DFTX
32.26
▼
−3.45%
Regular session
Nov 4 '26